Delivery Order SPE2DB22D3016-SPE2DB24FAZE1
Award Date
6/24/24
Potential Completion Date
7/16/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,865.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,679.17 firm fixed-price delivery order is for the supply of the prescription drug XALKORI 250 MG CAPSULE 60S. The contract has an ultimate completion date of May 19, 2023 and was awarded on April 28, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,356.89 firm fixed-price contract is for the supply of XALKORI 250 MG CAPSULE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 18, 2025 and was awarded on February 25, 2025. This delivery order is issued under Amerisourcebergen's existing $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $12,877.79 firm fixed price delivery order is for the supply of 4565736120 XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for delivering a comprehensive range of medical...
This federal contract award, valued at $12,679.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product XALKORI 200 MG CAPSULE 60S. The contract, valued at $12,865.21, is a delivery order awarded by the Defense Logistics Agency (DLA) with a completion date of May 14, 2024. The contract is a firm fixed-price arrangement with no set-aside designations. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,356.89, is for the delivery of XALKORI 250 MG CAPSULE 60S, a medication used in the treatment of certain types of cancer. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, involves the delivery of the pharmaceutical product XALKORI 250 MG CAPSULE 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $12,877.79 firm fixed price delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, valued at up to $12,877.79, is for the delivery of the prescription drug XALKORI 250 MG CAPSULE 60S. This is a Firm Fixed Price contract with a completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $51,511.20 firm fixed-price delivery order contract provides for the supply of XALKORI 250 MG CAPSULE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA,...